CURRICULUM VITAE
CAPT Robert John Berry
Medical Epidemiologist USPHS (retired)
August, 2012
PRE-MEDICAL EDUCATION: University of Utah,
Salt Lake City, Utah, 1964-68,
B. S., Magna cum Laude
MEDICAL EDUCATION: Cornell University Medical College,
New York City, New York, 1968-73, M.D.
Tulane University School of Public Health
and Tropical Medicine, 1976-77, M.P.H.T.M.
POSTGRADUATE MEDICAL TRAINING: RESIDENCY:
Pediatrics, PL-1 and PL-2
The New York Hospital, New York City, New York,
1973-75
Pediatrics, PL-3
Charity Hospital of Louisiana, New Orleans, Tulane
Division, 1975-76
Preventive Medicine
Centers for Disease Control, Atlanta, Georgia, 1982-84
MEDICAL SPECIALTY:
Board Certified Pediatrics - 1981
Board Eligible Preventive Medicine - 1984
LICENSURE:
New York State Board of Medical Examiners, 1974, No. 122648
Medical Board of Western Australia, 1980, No. 6241
PROFESSIONAL ASSOCIATIONS:
American College of Epidemiology
Member of Ethics and Standards of Practice Committee
American Epidemiological Society
American Pediatric Society
American Public Health Association
Society for Epidemiologic Research
Society for Pediatric and Perinatal Epidemiologic Research
Member of Program Committee
1
PHS AWARDS:
Distinguished Service Medal – 27 January 2011 – In Recognition of:
Promoting the use of folic acid to prevent neural tube defects
through innovative analytical work and ground-breaking
publications.
Unit Commendation – 30 June 2004 – Exemplary work in the proposed
Transformation of the Commissioned Corps & Health Care for
Atlanta based PHS Officers.
Meritorious Service Medal – 21 December 1999 - For improved child
health worldwide through the design, implementation, analysis,
and publication of a study in China of folic acid for prevention of
birth defects.
Bicentennial Unit Commendation – 01 January 1998
Foreign Duty Award – 9 November 1993 - Foreign duty assignment in
Beijing, China
Regular Corps Ribbon – 21 October 1993
Commendation Medal 05 December 1990 - Outstanding contribution to
the prevention of birth defects through his design and development
of a trial in China of the use of periconceptional vitamins to
prevent spina bifida and anencephaly.
Commendation Medal – 26 December 1989 - Outstanding contribution to
the improvement of infant health through the development of
innovative approaches to information management and
microcomputer training.
Unit Commendation – 08 April 1988 - Outstanding individual and group
performance for work on the study of the risks of birth defects
among multivitamin users
Unit Commendation – 05 May 1987 - Scientific leadership and excellence
in the National Infant Mortality Surveillance project, contributing
to the promotion of maternal and infant health in the United States.
Non- PHS AWARDS
2011 – National Birth Defects Prevention Network - February 28, 2011 –
The Godfrey P. Oakley, Jr. Award for 2010 – Honoring an
individual who has made significant contributions to the field of
birth defects.
2009 - CDC- nomination for 2008 Charles C. Shepard Science Award
2000 - HHS - Secretary's Award for Distinguished Service - The ChinaUS Collaborative Project for Neural Tube Defect Prevention.
1999 - CDC- nomination for 1998 Charles C. Shepard Science Award
1994 - Friendship Award - Highest award given by the Chinese
government to foreigners working in China. Awarded for work on
public health projects in China.
1989 - CDC- nomination for 1988 Charles C. Shepard Science Award
.
2
PROFESSIONAL EXPERIENCE AND ACCOMPLISHMENTS IN USPHS:
November 2009 to Present:




Prevention Research Branch
Division of Birth Defects and Developmental Disabilities, National
Center on Birth Defects and Developmental Disabilities, Centers
for Disease Control and Prevention
Supervised ongoing work in China, which is a cooperative project with China CDC
and the National Cancer Institute on the follow-up of the original cohort.
Directing analysis of NHANES on the different sources of folic acid. It is important
to separate lower-dose folic acid from mandatory fortification from higher-dose folic
acid from ready-to-eat cereals and supplements when discussing potential adverse
effects.
Evaluating the potential adverse effects of folic acid on a variety of outcomes
including reproductive, cognition, stroke, and cancer.
Provided assistance and support to national and international groups to develop a
rational approach to determine the appropriate level of folic acid to use to fortify
wheat flour around the world, especially countries in the developing world.
August 2007 to Present:
Adjunct Professor in the Department of Epidemiology and the
Hubert Department of Global Health,
Rollins School of Public Health
Emory University, Atlanta, GA
April 2007 to Nov 2009:
Birth Defects Epidemiology Team Leader
Division of Birth Defects and Developmental Disabilities, National
Center on Birth Defects and Developmental Disabilities, Centers
for Disease Control and Prevention



Supervised ongoing work in NBDPS, the cooperative project with Peking University
Health Sciences Center and analysis of NHANES data for dietary intake and
supplement use from years 2001 – 2004 and 2003 – 2006
Evaluating the potential beneficial and adverse effects of folic acid on a variety of
outcomes including reproductive, cognition, stroke, and cancer.
Provided assistance and support to national and international groups to develop a
rational approach to determine the appropriate level of folic acid to use to fortify
wheat flour around the world, especially countries in the developing world.
February 2005 to April 2007: Acting Birth Defects Epidemiology Team Leader
Division of Birth Defects and Developmental Disabilities, National
Center on Birth Defects and Developmental Disabilities, Centers
for Disease Control and Prevention

Supervised ongoing work in NBDPS, the cooperative project with Peking University
Health Sciences Center and analysis of NHANES data for dietary intake and vitamin
levels from years 2001 – 2004.
3


Evaluating the potential beneficial and adverse effects of folic acid on a variety of
outcomes including reproductive, cognition, stroke, and cancer.
Provided assistance and support to national and international groups to develop a
rational approach to determine the appropriate level of folic acid to use to fortify
wheat flour around the world, especially countries in the developing world.
April 2001 to January 2005: US Project Director - NTD Community Intervention Project in
China
Division of Birth Defects and Developmental Disabilities, National
Center on Birth Defects and Developmental Disabilities, Centers
for Disease Control and Prevention


Conducted and analyzed a follow-up of children whose mothers participated in a
Chinese community intervention program of folic acid to prevent the serious birth
defects spina bifida and anencephaly using the integrated databases on pregnancy and
birth defects created previously.
Evaluating the effect of folic acid taken during early pregnancy on other reproductive
outcomes including twinning, miscarriage, complications of pregnancy, fertility and
infant survival.
July 1996 to April 2001:



US Project Director - NTD Community Intervention Project in
China
Division of Birth Defects, Child Development, and Disabilities
and Health, National Center for Environmental Health, Centers
for Disease Control and Prevention
Designed and initiated a follow-up of children whose mothers participated in a
Chinese community intervention program of folic acid to prevent the serious birth
defects spina bifida and anencephaly using the integrated databases on pregnancy and
birth defects created previously.
Evaluating the effect of folic acid taken during early pregnancy on other reproductive
outcomes including twinning, miscarriage, complications of pregnancy, fertility and
infant survival.
Analyzed data from the Chinese folic acid intervention program and was primary
author of a paper published November 11, 1999 in the New England Journal of
Medicine (NEJM), which showed 85% reduction of neural tube defects in Northern
Counties where the rates are among the highest in the world and a 40% reduction in
Southern Counties where rates are similar to those in the US.
July 1991 to July 1996:

US Project Director - NTD Community Intervention Project
Department of Health Care Epidemiology
Beijing Medical University
People's Republic of China
Designed, developed and executed an evaluation of a Chinese community intervention
program of folic acid to prevent the serious birth defects spina bifida and anencephaly.
Monitored 950,000 births for birth defects; evaluated pill taking in over 250,000 women
4
enrolled between 1993 and 1995.
January 1985 to July 1991:

Medical Epidemiologist,
Division of Birth Defects and Developmental Disabilities,
Center for Environmental Health and Injury Control, Centers for
Disease Control.
Co-authored CDC case-control study of NTD’s which showed that mothers of children
who had neural tube defects had lower use of multivitamins than controls. This article
was one factor that led to randomized controlled studies in Europe which proved that
folic acid prevents spina bifida and anencephaly.
January 1983 to January 1985:

First chief of Perinatal Environmental Epidemiology Branch (PEEB); supervised design
and implementation of the very low birthweight study and surveillance of 5
developmental disabilities in metropolitan Atlanta.
July 1981 to June 1983:


Acting Chief,
Maternal and Child Health Studies Section,
Birth Defects Branch,
Chronic Diseases Division,
Center for Environmental Health,
Centers for Disease Control
EIS Officer, Birth Defects Branch,
Chronic Diseases Division,
Center for Environmental Health,
Centers for Disease Control
Designed and developed system to monitor spontaneous abortions among employees at
CDC.
Member of team that first reported valproic acid as causing spina bifida in France.
5
PROFESSIONAL EXPERIENCE BEFORE JOINING USPHS
February 1980 to January 1981:
Research Fellow, Department of Child
Health, University of Western Australia,
Perth, Western Australia.
July 1978 to January 1980:
Clinical Research Registrar,
Princess Margaret Hospital,
Subiaco, Western Australia.
July 1975 to June 1977:
Clinical Instructor PL3,
Tulane University School of Medicine,
Department of Pediatrics
New Orleans.
Assistant Visiting Physician, Pediatrics,
Tulane University Hospital, and Charity
Hospital of Louisiana, New Orleans.
Pediatrician, Desire-Florida Neighborhood Health Center,
New Orleans.
July 1973 to June 1975:
Clinical Instructor PL1-2,
The New York Hospital,
Department of Pediatrics
New York City.
August 1971 to May 1972:
Institute of Human Biology,
Goroka, Papua New Guinea.
WHO Consultations:
September 28 - October 10, 1985
WHO/EMRO Temporary Adviser, Workshop on the Risk
Approach in Maternal and Child Health, Amman, Jordan
June 2 - June 18, 1986
WHO/WPRO Consultant, Microcomputer Methods for
Data Management and Analysis, Beijing, China
June 17 - July 3, 1987
WHO/WPRO Consultant, Microcomputer Methods for
Data Management and Analysis, Beijing, China
6
PUBLICATIONS:
1.
Berry, R. J., M. Gracey and V.W. Bamford. Campylobacter jejuni carriers in Australian
Aboriginal communities. Medical Journal of Australia 1981;1:381. (letter).
2.
Berry, R. J. and M. Gracey. Diarrhoeal disease in Aboriginal and non-Aboriginal infants
and children in Western Australia. Medical Journal of Australia 1981;1:479-82.
3.
Burke, V., J. Robinson, R. J. Berry and M. Gracey. Detection of enterotoxins of
Aeromonas hydrophila by a suckling-mouse test. Journal of Medical Microbiology
1981;14:401-8.
4.
Burke, V., J. Robinson, H. M. Atkinson, M. Dibley, R. J. Berry and M. Gracey.
Exotoxins of Aeromonas hydrophila. The Australian Journal of Experimental Biology
and Medical Science 1981;59:753-61.
5.
Berry, R. J., K. A. Bettelheim and M. Gracey. Identification of enterotoxigenic
Escherichia coli by serogrouping. Lancet 1982;1:1124-5. (letter).
6.
Berry, R. J., K. A. Bettelheim and M. Gracey. Studies on enterotoxigenic Escherichia coli
isolated from persons without diarrhoea in Western Australia. J. Hygiene
1983;90:99-106.
7.
Berry, R. J., V. Burke and M. Gracey. A modified infant mouse assay for bacterial
enterotoxins. Transactions of the Royal Society of Tropical Medicine and Hygiene
1983;77:699-701.
8.
Dibley, M., F. Phillips, T. J. Mahoney and R. J. Berry. Oral rehydration fluids used in the
treatment of diarrhoea: Analysis of the osmolalities, and sodium, potassium and sugar
contents of commercial and home-made products. Medical Journal of Australia
1984;140:341-7.
9.
Berry, R. J., J. W. Buehler, L. T. Strauss, C. J. R. Hogue and J. C. Smith. Birth
weight-specific infant mortality due to congenital anomalies, 1960 and 1980. Public
Health Reports 1987;102:171-81.
10.
Mulinare, J., J. F. Cordero, J. D. Erickson, and R. J. Berry. Periconceptional use of
multivitamins and the occurrence of neural tube defects. JAMA 1988;260:3141-5.
11.
Wartenberg, D., V. J. Agamennone, D. Ozonoff, and R. J. Berry. A microcomputer-based
vital records data base with interactive graphic assessment for states and localities.
American Journal of Public Health 1989;79:1531-6.
12.
Mulinare, J., J. F. Cordero, J. D. Erickson, and R. J. Berry. Comment on Mills et al.
7
original article “The absence of a relationship between the periconceptional use of
vitamins and neural-tube defects”. N Eng J Med 1990;322:1083. (Letter).
13.
Yen, I.H., M.J. Khoury, J.D. Erickson, L.M. James, G.D. Waters, and R.J. Berry. The
changing epidemiology of neural tube defects, 1968-1989. American Journal of Diseases
of Children 1992;146:857-61.
14.
Moore, C.A., S. Li, Z. Li, S.X. Hong, H.Q. Gu, R.J. Berry, J. Mulinare, J.D. Erickson.
Elevated Rates of Severe Neural Tube Defects in a High-Prevalence Area in Northern
China. Am J of Med Genet 1997;73:113-8.
15.
Berry, R.J., Z. Li, J.D. Erickson, S. Li, et. al. Prevention of neural-tube defects with folic
acid in China. N Eng J Med 1999;341:1485-90.
16.
Berry, R.J., J. Gindler, L Botto. Neural-tube defects. N Eng J Med 2000;342:1136-7.
(Letter).
17.
Gindler, J., Z Li, R.J. Berry, J.C. Zheng, et. al. Consumption of folic acid supplements
during pregnancy and risk for miscarriage. Lancet 2001;358:796-800.
18.
Myers, M.F., S. Li, A. Correa-Villaseñor, Z. Li, C.A. Moore, S.X. Hong, R.J. Berry. Folic
Acid and Imperforate Anus in China. Am J of Epid 2001;154:1051-6.
19.
Berry, R.J., Z. Li. Folic acid alone prevents neural tube defects - evidence from the China
study. Epidemiology 2002;13:114-6.
20.
Li, Z., J. Gindler, H. Wang, R.J. Berry, S. Li, A. Correa, J.C. Zheng, J.D. Erickson, Y.
Wang. Folic acid supplements during early pregnancy and likelihood of multiple births: a
population-based cohort study. Lancet 2003;361:380-4).
21.
Li, S., C.A. Moore, Z. Li, R.J. Berry, J. Gindler, S. Hong, Y. Liu, J. Mulinare, L-Y.
Wong, H. Gu, and J.D. Erickson. A population-based birth defects surveillance system in
the People’s Republic of China. Paediatr Perinat Epidemiol 2003;17:287-93.
22.
Wang, H, J.D. Erickson, Z. Li, R.J. Berry, Evaluation of the informed consent process in
a randomized controlled clinical trial in China: The Sino-U.S. NTD project, The Journal
of Clinical Ethics 2004;15:61-75.
23.
Berry RJ, Kihlberg R, Devine O. Impact of in vitro fertilization on studies of folic acid
and twinning: modelling using population based Swedish vital records. BMJ 2005
Apr;330:815-8
24.
Bailey LB, Berry RJ. Folic acid supplementation and the occurrence of congenital heart
defects, orofacial clefts, multiple births, and miscarriage. Am J Clin Nutr
2005;81(suppl):1213S – 7S.
8
25.
Berry RJ, Kihlberg R. Use of folic acid supplements and risk for dizygotic twinning
(Letter). Early Hum Dev 2005;81:465-7.
26.
Berry RJ. Impact of ovarian stimulation on studies of twinning (Letter). Am J Obstet
Gynecol. 2005 Sep;193:1287-8.
27.
Yang QH, Botto LD, Erickson JD, Berry RJ, Sambell C, Johansen H, Friedman JM.
Improvement in Stroke Mortality in Canada and the United States, 1990 to 2002.
Circulation. 2006;113:1335-1343.
28.
Yang QH, Carter HK, Mulinare J, Berry RJ, Friedman JM, Erickson JD. Race/ethnicity
differences in folic acid intake among women of childbearing age in the United States
after folic acid fortification: findings from the National Health and Nutrition Examination
Survey, 2001–2002. Am J Clin Nutr. 2007;85:1409-16.
29.
Berry RJ, Carter HK, Yang QH. Cognitive impairment in older Americans in the age of
folic acid fortification. Am J Clin Nutr. 2007;86:265-7. (Letter).
30.
Hao L, Yang QH, Li Z, Bailey LB, Zhu JH, Hu DJ, Zhang BL, Erickson JD, Zhang L,
Gindler J, Li S, Berry, RJ. Folate status and homocysteine response to folic acid doses
and withdrawal among young Chinese women in a large-scale randomized double-blind
trial. Am J Clin Nutr, 2008;88:448-457.
31.
Cordero JF, Do A, Berry RJ. Review of interventions for the prevention and control of
folate and vitamin B12 deficiencies. Food Nutr Bull. 2008 Jun;29:S188-95.
32.
Yeung L, Yang QH, Berry RJ. Contributions of total daily intake of folic acid to serum
folate concentrations. JAMA 2008;300:2486-7.
33.
Crider KS, Cleves MA, Reefhuis J, Berry RJ, Hobbs CA, Hu DJ. Antibacterial
medication use during pregnancy and risk of birth defects: National Birth Defects
Prevention Study. Arch Pediatr Adolesc Med. 2009;163:978-85.
34.
Berry RJ, Mulinare J, Hamner HC. Folic acid fortification: Neural tube defect risk
reduction – A global perspective. In: Bailey LB, ed. Folate in health and disease, 2nd ed.
Boca Raton, Fla, USA: CRC Press, 2009:179-204.
35.
Yang Q, Cogswell ME, Hamner HC, Carriquiry A, Bailey LB, Pfeiffer CM, Berry RJ.
Folic acid source, usual intake, and folate and vitamin B-12 status in US adults: National
Health and Nutrition Examination Survey (NHANES) 2003-2006. Am J Clin Nutr
2010;91:64-72.
36.
Berry RJ, Bailey LB, Mulinare J, Bower C. Fortification of flour with folic acid. Food
Nutr Bull. 2010 Mar;29:S22-35.
9
37.
Tinker SC, Cogswell ME, Devine O, Berry RJ. Folic Acid Intake among US Women
Aged 15–44 Years, NHANES 2003–2006. Am J Prev Med 2010;38:534-42.
38.
Jin L, Cogswell M, Ye RW, Liu JM, Berry RJ, Hu D. Prevalence of Anemia among
Pregnant Women in Southeast China, 1993–2005. Pub Health Nutr 2010;13:1511-18.
39.
Cordero A, Mulinare J, Berry RJ, Boyle C, Dietz W, Johnston R, Leighton J, Popovic T.
CDC Grand Rounds: Additional Opportunities to Prevent Neural Tube Defects with Folic
Acid Fortification. MMWR 2010;59:980-4.
40.
Zhu JH, Hu D, Hao L, Zhang BL, Cogswell ME, Bailey L, Li Z, Berry RJ. Iron, folate,
and B12 deficiencies and their associations with anemia among women of childbearing
age in a rural area in northern China. Int J Vitam Nutr Res 2010;80:144-54.
41.
Yeung LF, Cogswell ME, Carriquiry AL, Bailey LB, Pfeiffer CM, Berry RJ.
Contributions of enriched cereal-grain products, ready-to-eat cereal, and supplements
containing folic acid to the folic acid and vitamin B-12 usual intake, and folate and
vitamin B-12 status in US children: National Health and Nutrition Examination Survey
2003–2006. Am J Clin Nutr. 2011;93:172–84.
42.
Crider KS, Bailey LB, Berry RJ. Folic Acid Food Fortification—Its History, Effect,
Concerns, and Future Directions. Nutrients. 2011;3(3):370-384.
43.
Crider KS, Zhu JH, Hao L, Yang QH, Yang TP, Gindler JG, Maneval D, Quinlivan E, Li
Z, Bailey LB, Berry RJ. Methylenetetrahydrofolate reductase 677C→T genotype is
associated with folate and homocysteine in a large population-based double-blind trial of
folic acid supplementation. Am J Clin Nutr. 2011;93:1365-1372; First published online
April 20, 2011. doi:10.3945/ajcn.110.004671.
44.
Zhang YL, Riehle-Colarusso T, Correa A, Li S, Feng XH, Gindler JS, Lin H, Webb C, Li
W, Trines J, Berry RJ, Luo Y, Jiang MF, Chen H, Sun XM, Li Z. Observed Prevalence of
Congenital Heart Defects from a Surveillance Study in China. J Ultrasound Med 2011;
30:989–995.
45.
Crider KS, Quinlivan E, Berry RJ, Hao L, Li Z, Maneval D, Yang TP, Rasmussen SA,
Yang QH, Zhu JH, Hu DJ, Bailey LB. Genomic DNA methylation changes in response to
folic acid supplementation and withdrawal in a population-based intervention study of
women of reproductive age, differential response in coagulated vs. uncoagulated blood.
PLoS ONE 2011;6(12): e28144. doi:10.1371/journal.pone.0028144.
46.
Crider KS, Berry RJ, Yang TP, Bailey LB. Folate and DNA methylation. Advances in
Nutrition. 2012;3:21-38; doi:10.3945/an.111.000992.
10
47.
Li S, Chao A, Li Z, Moore CA, Liu YH, Erickson JD, Hao L, Berry RJ. Folic Acid Use
and Non-syndromic Orofacial Clefts in China: A Prospective Cohort Study.
Epidemiology. 2012;23:423–432. doi: 10.1097/EDE.0b013e31824d0349.
48.
Pfeiffer CM, Hughes JP, Lacher DA, Bailey RL, Berry RJ, Zhang M, Yetley EA, Rader
JI, Sempos CT, Johnson CL. Trends of serum and red blood cell folate in the U.S.
population from pre- to post-fortification: National Health and Nutrition Examination
Survey 1988–2010. J Nutr 2012;142:894-900.
49.
Tinker SC, Cogswell ME, Hamner HC, Berry RJ. Usual folic acid intakes: a modeling
exercise assessing the impact of changes in the amount of folic acid in foods and
supplements, NHANES, 2003–2008. Public Health Nutrition. 2012; 15(7), 1216–1227,
ePub-doi:10.1017/S1368980012000638.
50.
Tinker SC, Hamner HC, Berry RJ, Bailey L, Pfeiffer CM. Does obesity modify the
association of supplemental folic acid with folate status among non-pregnant women of
childbearing age in the U.S? Birth Defects Res A Clin Mol Teratol, 2012, in press
51.
Chandler AL, Mosley BS, Berry RJ, Canfield MA, Qi YP, Shaw GM, Siega-Riz AM,
Hobbs CA. Neural Tube Defects and Maternal Intake of Micronutrients Related to OneCarbon Metabolism or Antioxidant Activity. Birth Defects Res A Clin Mol Teratol, 2012,
in press
52.
Lancet letter
11
PRESENTATIONS AT MEETINGS:
Scientific Program, Annual Meeting, Annual College of Paediatrics, Canberra, May 1979. “The
extent of childhood diarrhoeal disease throughout Western Australia.”
Australian Public Health Association, National Conference, May 1979. “The epidemiology of
childhood diarrhoea in Western Australia 1971-78.”
Second International Child Neurology Congress Sydney, November 1979.
“Pyruvate - dehydrogenase deficiency” (with P Silberstein)
Annual Meeting, Paediatric Research Society of Australia, Sydney, May 1980. “Enzyme-linked
immunosorbent assay (ELISA) for the detection of E. coli heat-labile enterotoxin.”
Scientific Program, Annual Meeting, Annual College of Paediatrics, Canberra, May 1981. “Oral
fluids to treat diarrhoea: What is available in Australia” (with MJ Dibley).
EIS Conference, Centers for Disease Control, Atlanta, April 1982. “Malathion and congenital
malformations: The role of ecologic inference.”
EIS Conference, Centers for Disease Control, Atlanta, April 1983. “Valproic acid and spina
bifida - France.”
Presidents Committee on Mental Retardation, Washington, DC, November 1983. “Rh disease
and rubella.”
11th Annual Region IV Conference on Maternal and Child Health, Chapel Hill, NC, April 1984.
“Evaluating data for program management and evaluation.”
Workshop on Incidence and Prevalence Data for Handicapping Conditions, Quail Roost
Conference Center, NC, September 1984. “Developing synthetic estimates from national data.”
National Environmental Health Conference, Atlanta, GA, October 1984. “Birth-death linkage,
low birth weight, fetal deaths and infant mortality.”
Prevention 85: Assessing Risks in a Hazardous World, Atlanta, GA, March 1985. “Issues in
infant mortality: The role of perinatal epidemiology in state maternal and child health programs.”
National Infant Mortality Surveillance Conference, Atlanta, Georgia, May 1, 1986. “Congenital
Anomalies, 1960 - 1980 comparison.”
Teratology Society, 1986 Annual Meeting. “Low-Birth-Weight Prevention - Need For A 1st
Trimester Agenda.” (with GP Oakley)
American Society of Human Genetics, 1987 Annual Meeting, San Diego, California, October 9,
1987. “Mother's perceptions of causes of birth defects - Implications for genetic counseling and
12
methodologic studies.” (with J Mulinare).
Society for Epidemiologic Research, 1988 Annual Meeting, Vancouver, British Columbia, June
1988. “Impact of etiologic fraction in environmental case-control studies.” (with R Zagraniski).
American Public Health Association, 1988 Annual Meeting, Boston, Massachusetts, November
15, 1988. “Uses and limitations of birth certificates for surveillance of birth weight
distributions.” (with D Wartenberg).
Society for Clinical Trials, 1989 Annual Meeting, Minneapolis, Minnesota, May 1989.
“Proposed Clinical Trial of Multivitamin Use for the Prevention of neural tube defects in China.”
Society for Epidemiologic Research, 1989 Annual Meeting, Birmingham, Alabama, June 1989.
“Computerized methods developed for the Early Pregnancy Detection Study.” (with Dr. N.
Ellish).
Society for Epidemiologic Research, 1989 Annual Meeting, Birmingham, Alabama, June 1989.
“Does Maternal Recall Bias Account For The Apparent Protective Effect Of Periconceptional
Multivitamin Use On The Occurrence Of Neural-Tube Defects.” (with J Mulinare).
American Society of Medical Genetics, 1994. “Sites of neural tube closure failure: a new
approach to the epidemiology of neural tube defects.” (with CA Moore)
American Society of Human Genetics, 1996. “Neural tube defects and Facial Features of
Holoprosencephaly: A Nonrandom Association.” (with CA Moore)
American Society of Human Genetics, 1997. “Descriptive epidemiology of polydactyly among
Chinese infants.” (with CA Moore)
Teratology Society, 1998 Annual Meeting, Palm Beach, Florida, June 1998. “Folic acid in
preventing neural tube defects in China.”
NTD 2000, 1999 Annual Meeting, Schlangenbad, Germany, August 1999. “Evaluation of a
community intervention of the prevention of neural tube defects with periconceptional folic acid
in the People’s Republic of China.”
Western Australian Birth Defects Registry, Twentieth Anniversary Scientific Symposium, April
27-28, 2000, “Folic acid for the prevention of neural tube defects in China.”
Society for Pediatric and Perinatal Epidemiologic Research, 14th Annual meeting, Toronto,
Canada, June 2001. “Pregnancy complications among women who took folic acid during early
pregnancy-Sino-US NTD Project.”
Society for Pediatric and Perinatal Epidemiologic Research, 14th Annual meeting, Toronto,
Canada, June 2001. “Growth of children whose mothers took folic acid during early pregnancy--Sino-U.S. NTD Project.”
Society for Pediatric and Perinatal Epidemiologic Research, 14th Annual meeting, Toronto,
13
Canada, June 2001. “Infant death among children whose mothers took folic acid during early
pregnancy-Sino-US NTD Project.”
Society for Pediatric and Perinatal Epidemiologic Research, 14th Annual meeting, Toronto,
Canada, June 2001. “Occurrence of miscarriage among women who took folic acid during early
pregnancy-Sino-US NTD Project.”
Society for Pediatric and Perinatal Epidemiologic Research, 14th Annual meeting, Toronto,
Canada, June 2001. “Multiple births among women who took folic acid during early pregnancy--Sino-U.S. NTD Project.”
Society for Pediatric and Perinatal Epidemiologic Research, 14th Annual meeting, Toronto,
Canada, June 12-13, 2001. “Fertility and pregnancy among women who took folic acid during
early pregnancy---Sino-U.S. NTD Project.”
2001 Congress of Epidemiology, Toronto, Canada, June 13-16, 2001. “A perinatal and child
health surveillance system in China --- Sino-U.S. NTD Prevention Project.”
2001 Congress of Epidemiology, Toronto, Canada, June 13-16, 2001. “Non-syndromic orofacial
clefts among the offspring of women who consumed folic acid during early pregnancy --- SinoU.S. NTD Prevention Project.”
2001 Congress of Epidemiology, Toronto, Canada, June 13-16, 2001. “Multiple births among
women who consumed folic acid supplements during early pregnancy --- Sino-U.S. NTD
Prevention Project.”
2001 Congress of Epidemiology, Toronto, Canada, June 13-16, 2001. “Complications of
pregnancy and delivery among women who consumed folic acid supplements during early
pregnancy --- Sino-U.S. NTD Prevention Project.”
2001 Congress of Epidemiology, Toronto, Canada, June 13-16, 2001. “Occurrence of
miscarriage among women who consumed folic acid supplements during early pregnancy --Sino-U.S. NTD Prevention Project.”
2001 Congress of Epidemiology, Toronto, Canada, June 13-16, 2001. “Infant mortality among
children whose mothers consumed folic acid supplements during early pregnancy --- Sino-U.S.
NTD Prevention Project.”
2001 Congress of Epidemiology, Toronto, Canada, June 13-16, 2001. “Growth of children
whose mothers consumed folic acid supplements during early pregnancy --- Sino-U.S. NTD
Prevention Project.”
2001 Congress of Epidemiology, Toronto, Canada, June 13-16, 2001. “Prevention of birth
defects with folic acid use --- Sino-U.S. NTD Prevention Project.”
2001 Congress of Epidemiology, Toronto, Canada, June 13-16, 2001. “Evaluation of the
14
informed consent process in a randomized controlled trial in China --- Sino-U.S. NTD
Prevention Project.”
Teratology Society, 2001 Annual Meeting, Montreal, Canada, June 2001. “Effect of
periconceptional folic acid on phenotypes of neural tube defects --- Sino-U.S. NTD Prevention
Project.”
Teratology Society, 2001 Annual Meeting, Montreal, Canada, June 2001. ”Periconceptional folic
acid and the gender of offspring with neural tube defects in a high-prevalence area of China --Sino-U.S. NTD Project.”
Teratology Society, 2001 Annual Meeting, Montreal, Canada, June 2001. ”Non-syndromic
orofacial clefts among the offspring of women who consumed folic acid during early pregnancy -- Sino-U.S. NTD Prevention Project.”
NTD 2002 annual meeting. Seabrook, South Carolina, May 2002. ” Multiple births among
women who consumed folic acid supplements during early pregnancy --- Sino-U.S. NTD
Prevention Project.”
Society for Pediatric and Perinatal Epidemiologic Research, 15th Annual meeting, Palm Springs,
California, June 17 - 18, 2002. “Folic acid use during pregnancy and children’s cognitive ability--Sino-U.S. NTD Project.”
Society for Epidemiologic Research, Annual meeting, Palm Springs, California, June 18 - 21,
2002. “Folic acid use during pregnancy and children’s cognitive ability---Sino-U.S. NTD
Project.”
Society for Epidemiologic Research, Annual meeting, Palm Springs, California, June 18 - 21,
2002. “Folic acid use during pregnancy and child behavior ---Sino-U.S. NTD Project.”
Society for Pediatric and Perinatal Epidemiologic Research, 16th Annual meeting, Atlanta,
Georgia, June 9 - 10, 2003. “ Mortality among Chinese children with birth defects.”
Society for Epidemiologic Research, Annual meeting, Atlanta, Georgia, June 10 - 13, 2003.
“Mortality among Chinese children with birth defects.”
Society for Epidemiologic Research, Annual meeting, Atlanta, Georgia, June 10 - 13, 2003.
“Evaluation of the reproductive health surveillance system in Haiyan County, China, 19932002.”
NTD 2003 annual meeting. Seabrook, South Carolina, September 2003. ”Non-syndromic
orofacial clefts among the offspring of women who consumed folic acid during early pregnancy -- Sino-U.S. NTD Prevention Project.”
Workshop on folate, folate fortification and twin gestations. Uppsala, Sweden 13-14 January
2004. Impact of assisted reproductive techonologies (ART) on studies of folic acid and twinning.
15
EUROFOODFOLATE. Warsaw, Poland, 11-14 February 2004. Impact of assisted reproductive
techonologies (ART) on studies of folic acid and twinning.
Society for Epidemiologic Research, Annual meeting, 2004. “Misclassification of strong
confounders: Artificial reproductive therapy, folic acid and the occurrence of twin births.”
Society for Epidemiologic Research, Annual meeting, 2005. “The prevalence of anemia, folate
deficiency, and vitamin B-12 deficiency among chinese women of child-bearing age - The
SINO-US birth defects prevention project.”
Society for Epidemiologic Research, Annual meeting, 2005. “Resurgence of neural tube defects
following a change in policy regarding premarital health examinations in Shijiazhuang, China The SINO-US birth defects prevention project.”
WHO Technical Consultation on Folate and Vitamin B12 Deficiencies. Geneva, Switzerland.
October 19, 2005. Public Health Strategies to Reduce Folate and B12 Deficiencies.
AACC World Grains Summit. San Francisco, CA. September 19, 2006. Setting the level of folic
acid used to fortify flour.
Scientific Meeting Commemorating the 30th Anniversary of the Spanish Collaborative Study of
Congenital Malformations (ECEMC). Madrid, Spain. October 17, 2006. “Could supplementation
and / or food fortification with folic acid have negative health effects?”
Academy of Sciences of Ukraine – Meeting to set the level of folic acid used to fortify flour.
Kiev, November 27, 2006. Use of folic acid to improve public health: Interpretation of
recommendations
Maternal and Child Health Epidemiology Conference. Atlanta, GA. December 8, 2006.
Evaluating the High-Risk Pregnancy Scoring System in the Reproductive Health Surveillance
System in Haiyan County, People’s Republic of China.
3rd international conference on birth defects and disabilities in developing world June 17 – 22,
2007. Folic Acid, Gene-Environment Interaction, and Birth Defects. Blood Folate and
Homocysteine Response to Folic Acid Supplementation by MTHFR genotype – Xianghe
County, People’s Republic of China.
The Teratology Society, 47th Annual Meeting. Pittsburgh, PA. June 28, 2007. Review of
evidence base for tolerable upper level of folic acid.
A2Z: The Use of Food Intake in Designing, Monitoring and Evaluating Mass Fortification
Programs. Washington DC, July 31, 2007. Source of dietary folic acid from NHANES 2001 –
2004.
NTD 5th Annual Meeting. Monterey, CA. Sept 24, 2007. Review of evidence base for tolerable
upper level and other potential adverse effects of folic acid
16
Experimental Biology. San Diego CA. April 2008. Effect of MTHFR 677C→T polymorphism
on folate status response to folic acid doses in large-scale randomized intervention trial in young
Chinese women.
Experimental Biology. San Diego CA. April 2008. Changes in global DNA methylation in
response to chronic consumption and withdrawal of folic acid is dependent on the MTHFR
677C→T polymorphism.
FFI workshop: Wheat Flour Fortification: Current Knowledge and Practical Applications
Atlanta, GA April 1, 2008. Folic Acid Workgroup Report - Issues on Safety of Folic Acid
Fortification.
FASEB. One carbon metabolism. Barga, Italy August 2008. Sources of folic acid and their
association with blood folate concentrations – NHANES, 2001-2004
APHA San Diego, CA. October 27, 2008 Folic Acid and NTDs: A Decade of Prevention. Other
health effects of folic acid and their implications for prevention.
European Food Safety Agency workshop: Folic acid: an update on scientific developments.
Uppsala, Sweden. January 21, 2009. Relation of dietary sources of folic acid to blood folate
concentrations for the assessment of cancer risk - NHANES 2001–2004.
Experimental Biology. New Orleans, LA. April 2009. Analysis of locus-specific DNA
methylation in response to chronic folic acid supplementation and withdrawal in Chinese
women.
Micronutrient Forum – Micronutrients, Health, and Development: Evidence-based Programs.
Satellite Session: Flour Fortification Recommendations - Folic Acid Work Group Report
Beijing, China May 13, 2009.
NTD 6th Annual Meeting. Burlington VT. Sept 2009. Folic Acid Source, Usual Intake, Folate
and Vitamin B12 Status in US Adults, 2003-2006.
March of Dimes - State of the Science: Folic Acid 2009. White Plains, NY. November 2, 2009.
Source of folic acid among the adult population - NHANES 2003–2006.
WHO/UNICEF/FFI Meeting on Implementation in Asia of the Recommendations on Wheat
Flour Fortification. Manila, Philippines. November 10, 2009. Report on Flour Fortification
Initiative’s Folic Acid and Vitamin B12 Work Groups.
Usual intake of folic acid and food folate by dietary source, and folate status in U.S. children 118 years old, NHANES 2003-2006. Experimental Biology. Anaheim, CA. April 2010.
National Birth Defects Prevention Network, 13th Annual Meeting. National Harbor, MD. March
9, 2010. Plenary Session: Science of Folic Acid.
17
FASEB. One carbon metabolism. Carefree AZ August 2010. Modeling and usual intake of folic
acid from fortified foods and supplements in U.S. adults, 2003-2006 National Health and
Nutrition Examination Surveys
Emory University, Rollins School of Public Health, Epidemiology Department Grand Rounds
Seminar Series. September 24, 2010. Folic Acid and Vitamin B12 Interaction.
National Birth Defects Prevention Network, 14th Annual Meeting. Orlando, FA. February 28 –
March 2, 2011. Plenary Session: Diverse data to address a common question: Are women of
childbearing potential consuming the recommended amount of folic acid?
Experimental Biology. Washington DC. April 2011. Folic Acid Fortification and the Prevalence
of Suboptimal Vitamin B12 Status without Anemia and Macrocytosis among Older Americans in
NHANES.
Pediatric Academic Society Annual meeting. Denver CO. May 2011. Are There Changes in
DNA Methylation in Response to Chronic Consumption and Withdrawal of Folic Acid?
18